Company Filing History:
10 out of 541 
Years Active: 2017-2023
Title: David Fairman: Innovator in Antibody Therapeutics
Introduction
David Fairman is a prominent inventor based in Cambridge, GB. He has made significant contributions to the field of antibody therapeutics, holding a total of 9 patents. His work focuses on innovative methods for treating tumors and developing antibodies that target specific proteins.
Latest Patents
Among his latest patents, Fairman has developed "Anti-B7-H1 antibodies for treating tumors." This patent outlines methods for treating B7-H1-expressing tumors by administering an effective amount of MEDI4736 or an antigen-binding fragment thereof. Another notable patent is for "Nucleic acids encoding anti-PAR2 antibodies and uses thereof." This disclosure provides antibodies and antigen-binding fragments capable of binding PAR2, with some embodiments binding in a pH-dependent manner. The patent also includes methods for making and using these antibodies and fragments.
Career Highlights
David Fairman is currently associated with Medimmune Limited, where he continues to advance his research in antibody development. His work has been instrumental in the progress of therapeutic options for cancer treatment.
Collaborations
Fairman collaborates with notable colleagues such as Rajesh Narwal and Paul Robbins, contributing to a dynamic research environment that fosters innovation.
Conclusion
David Fairman is a key figure in the field of antibody therapeutics, with a strong portfolio of patents that reflect his commitment to advancing medical science. His contributions are paving the way for new treatment options in oncology.